Showing results (301-310 of 362) with videos related to

Sort By:
Pageof 37
Menopause (New York, N.Y.)|July 26, 2011
Sleep problems after short-term hormone therapy suspension: secondary analysis of a randomized trialSarah E Tom, Melissa L Anderson, Carol A Landis, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2009
Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective studyChristine G Lee, Molly C Carr, Susan J Murdoch, et al.
Menopause (New York, N.Y.)|October 28, 2009
Hormone therapy and physical function change among older women in the Women's Health Initiative: a randomized controlled trialYvonne L Michael, Rachel Gold, JoAnn E Manson, et al.
Biochemical Pharmacology|March 29, 1994
The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)G T Tucker, M S Lennard, S W Ellis, et al.
Journal of the American Geriatrics Society|February 12, 2009
Angiotensin-converting enzyme inhibitor use and incident frailty in women aged 65 and older: prospective findings from the Women's Health Initiative Observational StudyShelly L Gray, Andrea Z LaCroix, Aaron K Aragaki, et al.
Menopause (New York, N.Y.)|December 6, 2017
Vasomotor symptom characteristics: are they risk factors for incident diabetes?Kristen E Gray, Jodie G Katon, Erin S LeBlanc, et al.
The American Journal of Medicine|August 18, 2009
Inflammation and thrombosis biomarkers and incident frailty in postmenopausal womenAlexander P Reiner, Aaron K Aragaki, Shelly L Gray, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 23, 2008
Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational StudyAndrea Z LaCroix, Shelly L Gray, Aaron Aragaki, et al.
Pageof 37